NGS-Based RNA-Seq Market to 2027 - Global Analysis and Forecasts By Product & Services (Sample Preparation, Sequencing Services, Sequencing Platform & Consumables and Data Analysis, Storage & Management), Technology (Sequencing by Synthesis, Nanopore Sequ

NGS-Based RNA-Seq Market to 2027 - Global Analysis and Forecasts By Product & Services (Sample Preparation, Sequencing Services, Sequencing Platform & Consumables and Data Analysis, Storage & Management), Technology (Sequencing by Synthesis, Nanopore Sequencing, Ion Semiconductor Sequencing and Single Molecule Real Time Sequencing), Application (Diagnostics, Drug Discovery, Precision Medicine and Others), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, Research Centers and Academic & Government Institutes and Others ) and Geography

In the report the NGS based RNA seq market, the market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.

The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer However, the market is likely face the restraining factors such as risks related to genetic data and high cost of NGS instruments market. The future trend that is likely to drive the market growth is barcode scanning for long reads sequences.

The NGS based RNA seq market as per the product & services the segment is segmented as sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. The market of sequencing platform has the highest market share in 2018, contributing to NGS based RNA seq market is of 38.3% and is expected to retain its dominance during the forecast period from 2018 to 2027. The sample preparation segment is further sub-segmented into method and workflow step. The method segment further divided as manual and automated. Likewise, the workflow step is sub-segmented as Library preparation & target enrichment, fragmentation, end repair & size selection and quality control. Among the method segment the automated segment is likely to hold the major market in the forecast period. Similarly. The Library preparation & target enrichment among the workflow step segment.

The technology segment of the NGS based RNA seq market includes sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing and single-molecule real-time (SMRT) sequencings. The technology segment for the NGS based RNA seq market was valued at US$ 1,414.59 Mn in 2018 and is estimated to reach US$ 7,984.90 Mn by 2027. The technology segment and is expected to be the fastest growing segment in the forecast period owing advantages of the NGS-based RNA seq offers more sensible and accurate gene expression, the technologies can be applied to any species and these are available in comparatively less price for the various arrays. The companies offering offers various advantages to the researchers through their products. For instance, Illumina, Inc. offer system that uses sequencing by synthesis technology is being widely utilized across the globe for the next generation sequencing. The SBS technology enables the robust performance & maintains the data quality, provides accurate bases and more. Hence, owing to the advantages of the sequencing by synthesis by technology market is likely to propel in the forecast period

Some of the major primary and secondary sources included in the report NGS based RNA seq market are National Institutes of Health, National Science Foundation, Canada foundation for innovation, African Society of Human Genetics, Department of Biotechnology, Dubai Health Authority, Human Heredity and Health in Africa, French National Cancer Institute, Japan Science and Technology Agency, Trinity Translational Medicine Institute and others.


1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. GLOBAL NGS BASED RNA SEQ MARKET - KEY TAKEAWAYS
3. GLOBAL NGS BASED RNA SEQ MARKET - MARKET LANDSCAPE
3.1 OVERVIEW
3.1 NGS Based RNA Seq Market - By Product & Services
3.1 NGS Based RNA Seq Market - By Technology
3.1 NGS Based RNA Seq Market - By Application
3.1 NGS Based RNA Seq Market - By End User
3.1 NGS Based RNA Seq Market - By Geography
3.2 PEST ANALYSIS
3.2.1 North America PEST Analysis
3.2 PEST Analysis
3 Pacific PEST Analysis
3.2 East & Africa PEST Analysis
3.2.5 South & Central America PEST Analysis
4. GLOBAL NGS BASED RNA SEQ MARKET - KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Reduced Cost of Genome Sequencing
4.1.2 Advancements in Sequencing Technology
4 Generation Sequencing for Cancer
4.2 KEY MARKET RESTRAINTS
4.2.1 Risks Related to Genetic Data
4 Cost of NGS Instruments
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Application of NSG in Biomarker Discovery and Precision Medicine
4.3.2 Different Programs for RNA Sequencing
4 TRENDS
4.4.1 Barcode Scanning for Long Reads Sequences
4 ANALYSIS OF DRIVERS AND RESTRAINTS
5. NGS BASED RNA SEQ MARKET - GLOBAL ANALYSIS
5 NGS BASED RNA SEQ MARKET REVENUE FORECASTS AND ANALYSIS
5 NGS BASED RNA SEQ MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
5 POSITIONING
5.4 PERFORMANCE OF KEY PLAYERS
5.4.1 Illumina, Inc.
5 Scientific Inc.
5 OPINIONS
6. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY PRODUCT & SERVICES
6.1 OVERVIEW
6 NGS-BASED RNA SEQ MARKET, BY PRODUCT & SERVICES, 2018 & 2027 (%)
6 PREPARATION MARKET
6.3.1 Overview
6 Preparation Market Revenue and Forecasts to 2027 (US$ Mn)
6
6.3.3.1 Overview
6.3 Market
6.3.3.2.1 Overview
6.3.3 Method Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.3.3 Automated Method Market
6.3.3.3.1 Overview
6.3.3.3 Automated Method Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4 Workflow Step Market
6.3.4.1 Overview
6.3.4.2 Library Preparation & Target Enrichment Market
6.3.4.2.1 Overview
6.3.4.2 Library Preparation & Target Enrichment Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.3 Fragmentation, End Repair & Size Selection Market
6.3.4.3.1 Overview
6.3.4.3 Fragmentation, End repair & Size Selection Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.4 Quality Control Market
6.3.4.4.1 Overview
6.3.4.4 Quality Control Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 SEQUENCING SERVICES MARKET
6.4.1 Overview
6.4 Sequencing Services Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 SEQUENCING PLATFORM & CONSUMABLES MARKET
6.5.1 Overview
6.5 Sequencing Platform & Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
6.6 DATA ANALYSIS, STORAGE & MANAGEMENT MARKET
6.6.1 Overview
6.6 Data Analysis, Storage & Management Market Revenue and Forecasts to 2027 (US$ Mn)
7. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY TECHNOLOGY
7.1 OVERVIEW
7 NGS-BASED RNA SEQ MARKET, BY TECHNOLOGY, 2018 & 2027 (%)
7.3 SEQUENCING BY SYNTHESIS (SBS) MARKET
7.3.1 Overview
7.3 Sequencing By Synthesis (SBS) Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 NANOPORE SEQUENCING MARKET
7.4.1 Overview
7.4 Nanopore Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 ION SEMICONDUCTOR SEQUENCING MARKET
7.5.1 Overview
7.5 Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
7 MOLECULE REAL TIME (SMRT) SEQUENCING MARKET
7.6.1 Overview
7 Molecule Real Time (SMRT) Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
8. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY APPLICATION
8.1 OVERVIEW
8 NGS-BASED RNA SEQ MARKET, BY APPLICATION, 2018 & 2027 (%)
8.3 DIAGNOSTICS MARKET
8.3.1 Overview
8.3 Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 DRUG DISCOVERY MARKET
8.4.1 Overview
8.4 Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 PRECISION MEDICINE MARKET
8.5.1 Overview
8.5 Precision Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 OTHER APPLICATIONS MARKET
8.6.1 Overview
8.6 Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
9. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY END USER
9.1 OVERVIEW
9 NGS-BASED RNA SEQ MARKET, BY END USER, 2018 & 2027 (%)
9.3 HOSPITALS & CLINICS MARKET
9.3.1 Overview
9.3 Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
9.4.1 Overview
9.4 Research Centers And Academic & Government Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET
9.5.1 Overview
9.5 Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 OTHER END USERS MARKET
9.6.1 Overview
9.6 Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
10. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027
10.1 OVERVIEW
10.2 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.3 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
10.3.1 North America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
10.3.2 North America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
10.4 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
10.5 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
10.6 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
10.7 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
10 BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.8 Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
10.8 Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
10 Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
10 Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
10.8 Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8 Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.8 Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.9 NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
10.9 NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
10.9 Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
10.9 Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
10.9 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.9 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.9 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.10 MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
10.10 NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
10.10 NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
10.10 Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
10.10 Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
10.10 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.10 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10.10 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027
11.1 OVERVIEW
11 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
11 Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
11 Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
11 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
11 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
11 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
11 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
11 BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.8 Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
11.8 Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
11 Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
11 Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
11.8 Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.8 Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.8 Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.9 GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.9.1 Germany NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
11.9.2 Germany NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
11.9.2.1 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
11.9.2.2 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
11.9.3 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.9.4 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.9.5 GERMANY NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.10 FRANCE NEXT GENERATION SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
11.10 NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
11.10 NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
11.10 Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
11.10 Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
11.10 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.10 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.10 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027
12.1 OVERVIEW
12.2 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.3 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
12 Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
12 Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
12.4 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
12.5 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
12.6 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
12.7 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
12.8 CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.8.1 China NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
12.8.2 China NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
12.8.2.1 China Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
12.8.2.2 China Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
12.8.3 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.8.4 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
12.8.5 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12.9 INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.9.1 India NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
12.9.2 India NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
12.9.2.1 India Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
12.9.2.2 India Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
12.9.3 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.9.4 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
12.9.5 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
12.10.1 Japan NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
12.10.2 Japan NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
12.10.2.1 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
12.10.2.2 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
12.10.3 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.10.4 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
12.10.5 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
13. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027
13.1 OVERVIEW
13 EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
13 EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
13.3 East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
13.3 East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
13 EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
13 EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
13 EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
13 EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
13.8 SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
13.8.1 Saudi Arabia NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
13.8.2 Saudi Arabia NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
13.8.2.1 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
13.8.2.2 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
13.8.3 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
13.8.4 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
13.8.5 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
13.9 UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
13.9.1 UAE NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
13.9.2 UAE NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
13.9.2.1 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
13.9.2.2 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
13.9.3 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
13.9.4 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
13.9.5 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
13 AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
13.10.1 South Africa NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
13.10.2 South Africa NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
13.10.2.1 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
13.10.2.2 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
13.10.3 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
13.10.4 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
13.10.5 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
14. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027
14.1 OVERVIEW
14.2 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
14.3 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
14.3.1 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
14.3.2 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
14.4 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
14.5 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
14.6 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
14.7 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
14 BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
14.8 NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn)
14.8 NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn)
14.8 Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn)
14.8 Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn)
14.8 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
14.8 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn)
14.8 NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn)
15. NGS-BASED RNA-SEQ MARKET -INDUSTRY LANDSCAPE
15.1 OVERVIEW
15 STRATEGIES IN THE NGS-BASED RNA-SEQ MARKET, 2016-2018
15.3 ORGANIC DEVELOPMENTS
15.3.1 Overview
15.4 ORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018
15.5 PRODUCT & SERVICE LAUNCH
15.5 Product & Service Launch By Players In The NGS-based RNA-seq Market
15.6 PRODUCT APPROVAL
15.6 Product Approval By Players In The NGS-based RNA-seq Market
15
15.7.1 The NGS-based RNA-seq Market By Other Growth Strategies
15.8 INORGANIC DEVELOPMENTS
15.8.1 Overview
15.9 INORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018
15.10 PARTNERSHIPS
15.10 Partnerships by Players in the NGS-based RNA-seq Market
15.11 COLLABORATIONS
15.11.1 Collaborations By Players In The NGS-based RNA-seq Market
15.12 EXPANSION
15 NGS-based RNA-seq Market By Expansion
15.13 ACQUISITIONS
15.13.1 Acquisitions By Players In The NGS-based RNA-seq Market
15.14 AGREEMENTS
15 NGS-based RNA-seq Market By Agreements
16. NGS-BASED RNA-SEQ MARKET-KEY COMPANY PROFILES
16.1 ILLUMINA, INC.
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Financial Overview
16.1.4 Product Portfolio
16 Analysis
16.1.6 Key Developments
16 FISHER SCIENTIFIC INC.
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Financial Overview
16.2.4 Product Portfolio
16 Analysis
16.2.6 Key Developments
16.3 PERKINELMER, INC.
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Financial Overview
16.3.4 Product Portfolio
16 Analysis
16.3.6 Key Developments
16.4 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Financial Information
16.4.4 Product Portfolio
16 Analysis
16.4.6 Key Developments
16.5 F. HOFFMANN-LA ROCHE LTD
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Financial Information
16.5.4 Product Portfolio
16 Analysis
16.5.6 Key Developments
16
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Financial Information
16.6.4 Product Portfolio
16 Analysis
16.6.6 Key Developments
16.7 AGILENT TECHNOLOGIES
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Financial Overview
16.7.4 Product Portfolio
16 Analysis
16.7.6 Key Developments
16.8 BGI
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Financial Overview
16.8.4 Product Portfolio
16 Analysis
16.8.6 Key Developments
16 NANOPORE TECHNOLOGIES
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Financial Overview
16.9.4 Product Portfolio
16 ANALYSIS
16.9.6 Key Developments
16.10 EUROFINS SCIENTIFIC
16 Facts
16.10.2 Business Description
16.10.3 Financial Overview
16.10.4 Product Portfolio
16.10.5 SWOT Analysis
16 Developments
17. APPENDIX
17.1 ABOUT THE INSIGHT PARTNERS
17.2 GLOSSARY OF TERMS
17.3 METHODOLOGY
17.3.1 Coverage
17.3.2 Secondary Research
17.3.3 Primary Research
LIST OF TABLES
TABLE 1. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 2. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 3. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 4. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 5. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 6. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 7. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 8. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 9. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 10. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 11. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 12. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 13. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 14. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 15. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 16. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 17. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 18. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 19. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 20. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 21. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 22. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 23. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 24. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 25. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 26. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 27. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 28. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 29. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 30. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 31. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 32. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 33. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 34. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 35. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 36. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 37 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 38 SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 39 SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 40 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 41 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 42 NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 43. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 44. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 45. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 46. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 47. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 48. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 49. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 50. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 51. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 52. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 53. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 54. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 55. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 56. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 57. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 58. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 59. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 60. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 61. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 62. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 63. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN)
TABLE 64. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN)
TABLE 65. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 66. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN)
TABLE 67. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN)
TABLE 68. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN)
TABLE 69. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (U

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook